Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 2697-2704

  Konings, Anna F ^a   Martin, Lois W ^a   Sharples, Katrina J ^a   Roddam, Louise F ^c   Latham, Roger ^c   Reid, David W ^b   Lamont, Iain L ^a,d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS ION; HEME; IRON; OUTER MEMBRANE PROTEIN; PYOVERDINE; SIDEROPHORE;

ADULT; ARTICLE; BACTERIAL GENE; CYSTIC FIBROSIS; FEMALE; HUMAN; INFECTION; IRON TRANSPORT; LUNG FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPUTUM; SPUTUM ANALYSIS;

ADULT; CATION TRANSPORT PROTEINS; CHRONIC DISEASE; CYSTIC FIBROSIS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; IRON; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SIDEROPHORES; SPUTUM; YOUNG ADULT;

EID: 84880656969     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00418-13     Document Type: Article

References (55)

1. Harrison F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology 153:917-923.
2. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951.
3. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. 2001. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pe-diatr. Pulmonol. 32:277-287.
4. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. 2001. Clinical outcome after early Pseudomonas aerugi-nosa infection in cystic fibrosis. J. Pediatr. 138:699-704.
5. Stenbit AE, Flume PA. 2011. Pulmonary exacerbations in cystic fibrosis. Curr. Opin. Pulm. Med. 17:442-447.
6. Stites SW, Walters B, O'Brien-Ladner AR, Bailey K, Wesselius LJ. 1998. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114:814-819.
7. Stites SW, Plautz MW, Bailey K, O'Brien-Ladner AR, Wesselius LJ. 1999. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am. J. Respir. Crit. Care Med. 160:796-801.
8. Reid DW, Carroll V, O'May C, Champion A, Kirov SM. 2007. Increased airway iron as a potential factor in the persistence of Pseudomonas aerugi-nosa infection in cystic fibrosis. Eur. Respir. J. 30:286-292.
9. Tate S, MacGregor G, Davis M, Innes JA, Greening AP. 2002. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57:926-929.
10. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibro-sis pathogenesis. Dev. Cell 3:593-603.
11. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
12. Schalk IJ. 2008. Metal trafficking via siderophores in Gram-negative bacteria: specificities and characteristics of the pyoverdine pathway. J. Inorg. Biochem. 102:1159-1169.
13. Michel L, Bachelard A, Reimmann C. 2007. Ferripyochelin uptake genes are involvedinpyochelin-mediated signalling in Pseudomonas aeruginosa. Microbiology 153:1508-1518.
14. Meyer JM, Neely A, Stintzi A, Georges C, Holder IA. 1996. Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect. Immun. 64: 518-523.
15. Takase H, Nitanai H, Hoshino K, Otani T. 2000. Impact of siderophore production on Pseudomonas aeruginosa infections in immunocompro-mised mice. Infect. Immun. 68:1834-1839.
16. Cunliffe HE, Merriman TR, Lamont IL. 1995. Cloning and characterization of pvdS, a gene required for pyoverdine synthesis in Pseudomonas aeruginosa: PvdS is probably an alternative sigma factor. J. Bacteriol. 177: 2744-2750.
17. Lamont IL, Beare PA, Ochsner U, Vasil AI, Vasil ML. 2002. Sidero-phore-mediated signaling regulates virulence factor production in Pseu-domonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 99:7072-7077.
18. Heinrichs DE, Poole K. 1996. PchR, a regulator of ferripyochelin receptor gene (jptA) expression in Pseudomonas aeruginosa, functions both as an activator and as a repressor. J. Bacteriol. 178:2586-2592.
19. Ochsner UA, Vasil AI, Vasil ML. 1995. Role of the ferric uptake regulator of Pseudomonas aeruginosa in the regulation of siderophores and exotoxin A expression: purification and activity on iron-regulated promoters. J. Bacteriol. 177:7194-7201.
20. Cornelis P. 2010. Iron uptake and metabolism in pseudomonads. Appl. Microbiol. Biotechnol. 86:1637-1645.
21. Cornelis P, Bodilis J. 2009. A survey of TonB-dependent receptors in fluorescent pseudomonads. Environ. Microbiol. Rep. 1:256-262.
22. Weaver VB, Kolter R. 2004. Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J. Bacteriol. 186:2376-2384.
23. Ochsner A, Johnson Z, Vasil ML. 2000. Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. Microbiology 146:185-198.
24. Cescau S, Cwerman H, Letoffe S, Delepelaire P, Wandersman C, Biville F. 2007. Heme acquisition by hemophores. Biometals 20:603-613.
25. Rossi MS, Paquelin A, Ghigo JM, Wandersman C. 2003. Haemophore-mediated signal transduction across the bacterial cell envelope in Serratia marcescens: the inducer and the transported substrate are different molecules. Mol. Microbiol. 48:1467-1480.
26. Kaur AP, Lansky IB, Wilks A. 2009. The role of the cytoplasmic heme-binding protein (PhuS) of Pseudomonas aeruginosa in intracellular heme trafficking and iron homeostasis. J. Biol. Chem. 284:56-66.
27. Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC. 2006. Feo-transport of ferrous iron into bacteria. Biometals 19:143-157.
28. WyckoffEE, Mey AR, Leimbach A, Fisher CF, Payne SM. 2006. Characterization of ferric and ferrous iron transport systems in Vibrio cholerae. J. Bacteriol. 188:6515-6523.
29. WyckoffEE, Boulette ML, Payne SM. 2009. Genetics and environmental regulation of Shigella iron transport systems. Biometals 22:43-51.
30. Fetherston JD, Mier I, Jr, Truszczynska H, Perry RD. 2012. The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague. Infect. Immun. 80:3880-3891.
31. Marshall B, Stintzi A, Gilmour C, Meyer JM, Poole K. 2009. Citrate-mediated iron uptake in Pseudomonas aeruginosa: involvement of the citrate-inducible FecA receptor and the FeoB ferrous iron transporter. Microbiology 155:305-315.
32. Mey AR, WyckoffEE, Kanukurthy V, Fisher CR, Payne SM. 2005. Iron and Fur regulation in Vibrio cholerae and the role of Fur in virulence. Infect. Immun. 73:8167-8178.
33. Ochsner UA, Wilderman PJ, Vasil AI, Vasil ML. 2002. GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol. Microbiol. 45:1277-1287.
34. Schaible UE, Kaufmann SH. 2004. Iron and microbial infection. Nat. Rev. Microbiol. 2:946-953.
35. Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O'Toole GA, Stanton BA. 2008. The AF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing ironbioavailability. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L25-L37.
36. Haas B, Kraut J, Marks J, Zanker SC, Castignetti D. 1991. Siderophore presence in sputa of cystic fibrosis patients. Infect. Immun. 59:3997-4000.
37. Martin LW, Reid DW, Sharpies KJ, Lamont IL. 2011. Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24: 1059-1067.
38. King EO, Ward MK, Raney DE. 1954. Two simple media for the demonstration of pyocyanin and fluorescein. J. Lab. Clin. Med. 44:301-307.
39. Spencer DH, Kas A, Smith EE, Raymond CK, Sims EH, Hastings M, Burns JL, Kaul R, Olson MV. 2003. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185: 1316-1325.
40. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339:62-66.
41. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den HoffMJ, Moorman AF. 2009. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37: e45. doi :10.1093/nar/gkp045.
42. Balasubramanian D, Mathee K. 2009. Comparative transcriptome analyses of Pseudomonas aeruginosa. Hum. Genomics 3:349-361.
43. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277.
44. Vandenende CS, Vlasschaert M, Seah SY. 2004. Functional characterization of an aminotransferase required for pyoverdine siderophore biosynthesis in Pseudomonas aeruginosa PAO1. J. Bacteriol. 186:5596-5602.
45. Mossialos D, Ochsner U, Baysse C, Chablain P, Pirnay JP, Koedam N, Budzikiewicz H, Fernandez DU, Schafer M, Ravel J, Cornelis P. 2002. Identificationof new, conserved, non-ribosomal peptide synthetases from fluorescent pseudomonads involvedinthe biosynthesisofthe siderophore pyoverdine. Mol. Microbiol. 45:1673-1685.
46. Lamont IL, Martin LW. 2003. Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa. Microbiology 149:833-842.
47. Bustin SA. 2002. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29: 23-39.
48. Reimmann C, Serino L, Beyeler M, Haas D. 1998. Dihydroaeruginoic acid synthetase and pyochelin synthetase, products of the pchEF genes, are induced by extracellular pyochelin in Pseudomonas aeruginosa. Microbiology 144:3135-3148.
49. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, Hoiby N, Molin S. 2008. In situ growth rates and biofilm development of Pseu-domonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190:2767-2776.
50. Son MS, Matthews WJ, Jr, Kang Y, Nguyen DT, Hoang TT. 2007. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogene-sis in the lungs of cystic fibrosis patients. Infect. Immun. 75:5313-5324.
51. Belasco JG, Higgins CF. 1988. Mechanisms of mRNA decay in bacteria: a perspective. Gene 72:15-23.
52. Evguenieva-Hackenberg E, Klug G. 2011. New aspects of RNA processing in prokaryotes. Curr. Opin. Microbiol. 14:587-592.
53. Boulette ML, Payne SM. 2007. Anaerobic regulation of Shigella flexneri virulence: ArcA regulates Fur and iron acquisition genes. J. Bacteriol. 189: 6957-6967.
54. Wang Y, Wilks JC, Danhorn T, Ramos I, Croal L, Newman DK. 2011. Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J. Bacteriol. 193:3606-3617.
55. Cox CD. 1986. Role of pyocyanin in the acquisition of iron from trans-ferrin. Infect. Immun. 52:263-270.